Scientists have discovered a new virus in American shrews and have raised concerns about its potential ability to infect ...

Keymed Biosciences is currently studying OM336 (CM336 ... initial data came from CAR-T cell therapies," said Shinichiro Fuse, PhD, Business Unit Partner with TPG Life Sciences Innovations.

Company Profile Year-on-year gain: 2,131 percent Market cap: C$391.38 million Share price: C$56.00 Bright Minds Biosciences is ... are engineered to fuse with specific molecules to optimize ...

Japanese researchers combined artificial intelligence (AI) and robotics technology to develop a fully automated system to find the best culturing method for turning induced pluripotent stem (iPS ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

MIAMI, January 10, 2025--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

Image courtesy of Colossal Biosciences.(Colossal Biosciences) Colossal Biosciences announced Wednesday it had reached a $10 billion valuation, putting it in rare territory among Texas startups.

Sojo Industries, a technology company specializing in advanced robotics, mobile manufacturing, and modular packaging solutions for food and beverage assembly, today announced that its Sojo Shieldtm ...

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies that detect diseases at different stages of progression. Akoya investors ...

Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in an attempt to re-introduce extinct animals, hopes to bring that tusked beast back in the world by late 2028.